Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gynecology

Free Subscription 10.11.2025 8 Am J Obstet Gynecol 1 Am J Surg Pathol 1 BMC Cancer 2 Br J Cancer 1 Diagn Cytopathol 4 Eur J Obstet Gynecol Reprod Biol 11 Gynecol Oncol 4 Hum Reprod 4 Int J Cancer 7 Int J Gynaecol Obstet 1 Int J Radiat Oncol Biol Phys 1 JAMA 2 Lancet 1 Obstet Gynecol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. RANI J, Sharma S, Dubey S
   Doxycycline versus levofloxacin combined with tinidazole for treating chronic endometritis (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 3:S0002-9378(25)00816.
   PubMed        
   
   
2. LIU Y, Zhao Z, Qu D
   Doxycycline versus levofloxacin combined with tinidazole for treating chronic endometritis (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 3:S0002-9378(25)00817.
   PubMed        
   
   
3. OSTENFELD EB, Bjornholt SM, Jensen PT
   Lymph node removal and long-term lymphedema in cervical cancer. (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00819.
   PubMed        
   
   
4. LI Q
   Long-term lymphedema and quality of life following lymph node staging in early cervical cancer (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00818.
   PubMed        
   
   
5. WILKE RN, Pennington KP, Gootzen TA, Steenbeek MP, et al
   Salpingectomy in individuals at high risk for tubo-ovarian cancer - consensus and precaution.
   Am J Obstet Gynecol. 2025 Nov 1:S0002-9378(25)00820.
   PubMed         Abstract available
   
   
6. YAN Q, Zhang Y, Blue NR, Truong B, et al
   Genetic Associations with Placental and Pregnancy Proteins in Maternal Serum Identify Biomarkers for Hypertension in Pregnancy.
   Am J Obstet Gynecol. 2025 Nov 1:S0002-9378(25)00812.
   PubMed         Abstract available
   
   
7. BUJOLD E, Rolnik DL, Poon L, Syngelaki A, et al
   The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first trimester risk.
   Am J Obstet Gynecol. 2025 Oct 31:S0002-9378(25)00808.
   PubMed         Abstract available
   
   
8. MORENO-SPARKS A, Shivraj P, Young A, Kincaid H, et al
   Assessing Implementation of Research Requirements in Obstetrics and Gynecology Subspecialty Fellowship.
   Am J Obstet Gynecol. 2025 Oct 30:S0002-9378(25)00810.
   PubMed        
   
   

   
   Am J Surg Pathol

9. LIN LH, Buza N, Devouassoux-Shisheboran M, Kaur B, et al
   Atypical Placental Site Nodule and Related Lesions: Interobserver Reproducibility.
   Am J Surg Pathol. 2025 Nov 6. doi: 10.1097/PAS.0000000000002478.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. ZHOU Y, Guo X, Han J, Ding W, et al
    DDR1 drives cervical cancer progression and immune evasion: a bioinformatics analysis with experimental verification.
    BMC Cancer. 2025;25:1716.
    PubMed         Abstract available
    
    

    
    Br J Cancer

11. COLIN-LEITZINGER C, Aranzabal O, Johnson CE, Alberg AJ, et al
    Use of non-prescription analgesic medications and survival among Black women with ovarian cancer.
    Br J Cancer. 2025 Nov 5. doi: 10.1038/s41416-025-03254.
    PubMed         Abstract available
    
    
12. LOKMAN NA, Macpherson AM, Thompson AR, Price ZK, et al
    Proteomics analysis of serum extracellular vesicle identifies UCHL1 as a potential therapeutic target for high grade serous ovarian cancer.
    Br J Cancer. 2025 Nov 5. doi: 10.1038/s41416-025-03244.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

13. KOYUNCUER A, Ramazanoglu AF, Etli M, Serifoglu L, et al
    Improving Diagnostic Accuracy: Evaluation of Papanicolaou Staining With Rapid Hematoxylin-Eosin Staining Technique in Intraoperative Touch Imprint Cytology in Central Nervous System Neoplasms: A Prospective Cohort Study.
    Diagn Cytopathol. 2025 Nov 4. doi: 10.1002/dc.70042.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

14. KARIMAN SS, Depmann M, Lazarov K, van den Heuvel JFM, et al
    Patient perspectives on telemonitoring in low- and high-risk pregnancies: A feasibility study using a wireless fetal heart rate monitor.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114803.
    PubMed         Abstract available
    
    
15. RESTA C, Xiong R, Sturrock S, Story L, et al
    Non-invasive prenatal testing for the diagnosis of sickle cell disease in high-risk pregnancies: A systematic review and statistical summary of the current literature.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114799.
    PubMed         Abstract available
    
    
16. DALTON SE, Meeks H, Fraser A, Etcitty D, et al
    Familial risk of placental abruption.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114801.
    PubMed         Abstract available
    
    
17. AFZAL A, Abdelkader OKS, Abd-ElGawad M, Dean YE, et al
    Menstrual irregularities and cardiometabolic risk: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114796.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

18. NOZAKI T, Sakamoto I, Kagami K, Matsuda K, et al
    Preoperative molecular classification of endometrial cancer: Validation through biopsy and matched hysterectomy specimens.
    Gynecol Oncol. 2025;203:105-111.
    PubMed         Abstract available
    
    
19. WHITE VM, Langdale LM, Eroh KD, Ackermann MK, et al
    Experiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters.
    Gynecol Oncol. 2025;203:112-118.
    PubMed         Abstract available
    
    
20. MOUFARRIJ S, Friedman CF, Freeman S, Green H, et al
    A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
    Gynecol Oncol. 2025;203:97-104.
    PubMed         Abstract available
    
    
21. BASHI A, Chen L, Rouse K, Elkin EB, et al
    Cost-effectiveness of biomarker-based and universal strategies for the treatment of advanced-stage endometrial cancer.
    Gynecol Oncol. 2025;203:130-138.
    PubMed         Abstract available
    
    
22. PARK J, Lee D, Kim S, Kim YN, et al
    Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression.
    Gynecol Oncol. 2025;203:151-157.
    PubMed         Abstract available
    
    
23. WASHINGTON C, Dwivedi SKD, Gunderson-Jackson C, Walker J, et al
    Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.
    Gynecol Oncol. 2025;203:158-164.
    PubMed         Abstract available
    
    
24. TISCHER KM, Islam NS, McGree ME, Tapia AL, et al
    Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy.
    Gynecol Oncol. 2025;203:165-170.
    PubMed         Abstract available
    
    
25. BLANK SV, Frey MK
    Does a diagnosis of breast cancer reduce ovarian cancer risk in BRCA1/2 3 carriers: Why is this a question?
    Gynecol Oncol. 2025;201:A3-A4.
    PubMed        
    
    
26. KHADRAOUI W, Felix AS, Meade CE, Chalif J, et al
    Prognostic and demographic patterns in serous tubal intraepithelial carcinoma: A National Cancer Database study.
    Gynecol Oncol. 2025;201:76-82.
    PubMed         Abstract available
    
    
27. FULGIONE C, Inzani F, Raffone A, Raimondo D, et al
    Prognosis of HPV-independent, p53-wild-type vulvar squamous cell carcinoma: A systematic review and meta-analysis.
    Gynecol Oncol. 2025;201:210-215.
    PubMed         Abstract available
    
    
28. NEPHEW KP, Drapkin R, Lang J, Zhuravlev Y, et al
    The 15th Biennial Rivkin Center ovarian cancer research symposium.
    Gynecol Oncol. 2025;201:A1-A2.
    PubMed         Abstract available
    
    

    
    Hum Reprod

29. BELL SO, Hwang S, Malloy S, Nobles J, et al
    Validating the current duration approach for measuring infertility prevalence using novel app data from the USA.
    Hum Reprod. 2025;40:2172-2180.
    PubMed         Abstract available
    
    
30. WRIGHT LI, Wangsaputra I, Garner T, Sharps MC, et al
    Identification of novel differentiation trajectories and gene network associations with ectopic pregnancy in fallopian tube epithelium.
    Hum Reprod. 2025 Nov 3:deaf200. doi: 10.1093.
    PubMed         Abstract available
    
    
31. DEL LLANO E, Rasschaert M, Arnoult C, Robert P, et al
    Administration of ethiodized poppy seed oil-based contrast agent into the uterus enhances fertilization rate in mice inseminated with low sperm numbers.
    Hum Reprod. 2025 Nov 3:deaf204. doi: 10.1093.
    PubMed         Abstract available
    
    
32. JANNINK TI, Bordewijk EM, Lehmann V, Hoek A, et al
    Patient characteristics associated with symptoms of anxiety, depression, and reduced body appreciation in women with polycystic ovary syndrome.
    Hum Reprod. 2025 Nov 3:deaf214. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

33. HABIBURRAHMAN M, Masrour N, Patel N, Piskorz AM, et al
    Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients.
    Int J Cancer. 2025 Nov 1. doi: 10.1002/ijc.70217.
    PubMed         Abstract available
    
    
34. SA P, Monteiro P, Henrique R, Lunet N, et al
    The cervical cancer screening program in the North of Portugal: Outcomes after nearly two decades of coexistence with the human papillomavirus vaccine.
    Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70196.
    PubMed         Abstract available
    
    
35. ANDERSEN K, Bonde J, Waldstrom M, Jakobsen MV, et al
    Evaluation of targeted next-generation sequencing for detection of HPV genotypes and sublineages in cervical liquid-based cytology SurePath samples from the Danish screening program.
    Int J Cancer. 2025 Sep 11. doi: 10.1002/ijc.70148.
    PubMed         Abstract available
    
    
36. SABBAGHIAN A, Lin H, Lim YP
    WBP2 and its network of transcription coregulators in an expanding repertoire of human cancers.
    Int J Cancer. 2026;158:218-231.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

37. YAMAGUCHI A, Keymeulen S, Chavez Jimenez ZN, Karunaratne MS, et al
    Effect of COVID-19 pandemic on incidence of pregnancy with tuberculosis: A quasi-experimental analysis.
    Int J Gynaecol Obstet. 2025 Nov 6. doi: 10.1002/ijgo.70649.
    PubMed        
    
    
38. RAMASAUSKAITE D, Purandare N, Diaz I, Kvederaite-Budre G, et al
    Fibroids and pregnancy.
    Int J Gynaecol Obstet. 2025 Nov 6. doi: 10.1002/ijgo.70612.
    PubMed         Abstract available
    
    
39. MENAKAYA UA, Agholor KN, El Haieg D, Patel Y, et al
    Endometriosis in African women: Findings from a cohort of reproductive-age women attending an endometriosis ultrasound training program.
    Int J Gynaecol Obstet. 2025 Nov 6. doi: 10.1002/ijgo.70606.
    PubMed         Abstract available
    
    
40. GIOVANELLI SA, Torloni MR, Guazzelli CAF
    Incidence and risk factors for postplacental intrauterine device expulsion in a Brazilian hospital.
    Int J Gynaecol Obstet. 2025 Nov 4. doi: 10.1002/ijgo.70644.
    PubMed         Abstract available
    
    
41. JIANG Q, Yu H, Yuan H, Yuan L, et al
    Analysis of cases with prenatal diagnosis of mosaicism: Indications, methods of prenatal diagnosis, and pregnancy outcome follow-up.
    Int J Gynaecol Obstet. 2025 Nov 4. doi: 10.1002/ijgo.70640.
    PubMed         Abstract available
    
    
42. FUJITA H, Okamoto K, Kato H, Watari H, et al
    Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
    Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
    PubMed         Abstract available
    
    
43. MAUNY L, Mimoun C, Michel M, Tate B, et al
    Socioeconomic impact on quality of care in pelvic gynecological cancers.
    Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70593.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

44. BROWN MH, Pollock AE, Sun K, Marter K, et al
    Comparing Acute Toxicity of Proton and Photon Radiotherapy in Newly Diagnosed Gynecologic Primaries.
    Int J Radiat Oncol Biol Phys. 2025 Nov 2:S0360-3016(25)06421.
    PubMed         Abstract available
    
    

    
    JAMA

45. PANT S
    ACOG Issues Contraception Access Guidance.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19726.
    PubMed        
    
    

    
    Lancet

46. SURYAWANSHI H, Gemmell LC, Morgan S, Koustas G, et al
    First clinical pregnancy following AI-based microfluidic sperm detection and recovery in non-obstructive azoospermia.
    Lancet. 2025 Oct 31:S0140-6736(25)01623-X. doi: 10.1016/S0140-6736(25)01623.
    PubMed        
    
    
47. ANDERSON DJ, Bearak JM, Grimstad FW, Palanee-Phillips T, et al
    Biomedical innovations in contraception: gaps, obstacles, and solutions for sexual and reproductive health.
    Lancet. 2025;406:2119-2132.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

48. KAWAKITA T, Hayasaka M, Harper AM, Brush J, et al
    Association Between Neighborhood Social Determinants of Health and Stillbirth.
    Obstet Gynecol. 2025 Nov 7. doi: 10.1097/AOG.0000000000006115.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.